Literature DB >> 8568251

T cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice.

M C Kullberg1, J A Berzofsky, D L Jankovic, S Barbieri, M E Williams, P Perlmann, A Sher, M Troye-Blomberg.   

Abstract

We describe a novel amplification mechanism underlying the increased early IL-4 production observed in Schistosoma mansoni-infected mice in response to a non-parasite Ag, sperm whale myoglobin (SwMb). Earlier studies have shown that splenic Fc epsilon R+ non-B, non-T (NBNT) cells from schistosome-infected mice secrete IL-4 after stimulation with parasite Ag. We now demonstrate that purified NBNT cells from SwMb-immunized S. mansoni-infected mice do not respond directly to SwMb, but produce IL-4 in response to IL-3. Accordingly, we show that the early SwMb-specific IL-4 response of spleen cells (SC) from immunized infected mice is dependent on IL-3 and on CD4+ T cells. Thus, most of the early SwMb-induced IL-4 from SC of infected mice appears to be produced by NBNT cells triggered by IL-3 synthesized by SwMb-specific CD4+ T cells. IL-3-induced IL-4 production was also observed in purified NBNT cells from immunized uninfected mice, but the frequency and/or IL-4-producing capacity of splenic IL-3-responsive cells was found to be 8 to 16 times higher in immunized infected animals. IL-4 production by purified CD4+ cells from immunized infected mice was also seen after SwMb stimulation, but this response showed slower kinetics than those of total SC, was IL-3-independent, and on average threefold greater than that by CD4+ cells from immunized uninfected controls. Thus, increased SwMb-induced IL-4 production in immunized S. mansoni-infected mice results from direct synthesis by CD4+ T cells, as well as their stimulation via IL-3 of an expanded population of NBNT cells. The latter pathway may serve as an amplification loop for Th2-cytokine responses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8568251

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Immune polarization by hookworms: taking cues from T helper type 2, type 2 innate lymphoid cells and alternatively activated macrophages.

Authors:  Meera G Nair; De'Broski R Herbert
Journal:  Immunology       Date:  2016-03-31       Impact factor: 7.397

Review 2.  Functional heterogeneity in the basophil cell lineage.

Authors:  Mark C Siracusa; Elia D Tait Wojno; David Artis
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

3.  Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections.

Authors:  H Helmby; M Kullberg; M Troye-Blomberg
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

4.  Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression.

Authors:  Steven K Lundy; Nicholas W Lukacs
Journal:  Front Immunol       Date:  2013-02-20       Impact factor: 7.561

5.  CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling.

Authors:  D Jankovic; A W Cheever; M C Kullberg; T A Wynn; G Yap; P Caspar; F A Lewis; R Clynes; J V Ravetch; A Sher
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

6.  Cellular immune responses in peripheral blood lymphocytes of Giardia infected squirrel monkey (Saimiri boliviensis boliviensis) treated with Fenbendazole.

Authors:  Pramod N Nehete; Gregory Wilkerson; Bharti P Nehete; Sriram Chitta; Julio C Ruiz; Henrieta Scholtzova; Lawrence E Williams; Christian R Abee; John A Vanchiere
Journal:  PLoS One       Date:  2018-11-09       Impact factor: 3.240

7.  Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite.

Authors:  Booki Min; Melanie Prout; Jane Hu-Li; Jinfang Zhu; Dragana Jankovic; Ellen S Morgan; Joseph F Urban; Ann M Dvorak; Fred D Finkelman; Graham LeGros; William E Paul
Journal:  J Exp Med       Date:  2004-08-16       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.